Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: Novel insights into the mechanism of t(14;18) translocation

Blood

Volumn 95, Issue 11, 2000, Pages 3520-3529

  Jäger, Ulrich ^b   Böcskör, Silke ^b   Le, Trang ^b   Mitterbauer, Gerlinde ^b   Bolz, Ingrid ^b   Chott, Andreas ^b   Kneba, Michael ^b   Mannhalter, Christine ^b   Nadel, Bertrand ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHROMOSOME 14; CHROMOSOME 18; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA SYNTHESIS; FOLLICULAR LYMPHOMA; GENE INSERTION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0343953047     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3520     Document Type: Article

References (48)

1. Seto M, Jaeger U, Hockett RD, et al. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-lg fusion gene in lymphoma. EMBO J. 1988;7:123-131.
2. McDonnell TJ, Deane N, Platt FM, et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989;57:79-88.
3. Tsujimoto Y, Yunis J, Onorato-Showe L, et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science. 1984;224: 1403-1406.
4. Bakhshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 1985;41:899-906.
5. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science. 1985;229: 1390-1393.
6. Cleary ML, Sklar J. Nudeotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci U S A. 1985; 82:7439-7443.
7. Bakhshi A, Wright JJ, Graninger W, et al. Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci U S A. 1987;84:2396-2400.
8. Tsujimoto Y, Louie E, Bashir MM, Croce CM.The reciprocal partners of both the t(14;18) and the t(11;14) translocations involved in B-cell neoplasms are rearranged by the same mechanism. Oncogens. 1988;2:347-351.
9. Cotter F, Price C, Zucca E, Young BD. Direct sequence analysis of the 14q+ and 18q-chromosome junctions in follicular lymphoma. Blood. 1990;76:131-135.
10. Wyatt RT, Rudders RA, Zelenetz A, Delellis RA, Krontiris TG. BCL2 oncogene translocation is mediated by a chi-like consensus. J Exp Med. 1992; 175:1575-1588.
11. Meijerink JP, Raemaekers JM, Mensink EJ. New type of t(14;18) in a non-Hodgkin's lymphoma provides insight in molecular events in early B-cell differentiation. Br J Haematol. 1995;91:630-639.
12. Stamatopoulos K, Kosmas C, Belessi C, et al. t(14;18) chromosomal translocation in follicular lymphoma: an event occurring with almost equal frequency both at the D to J(H) and at later stages in the rearrangement process of the immunoglobulin heavy chain gene locus. Br J Haematol. 1997;99:866-872.
13. Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv Immunol. 1994;56:27-150.
14. Gellert M. Recent advances in understanding V(D)J recombination. Adv Immunol. 1997;64: 39-64.
15. Crescenzi M, Seto M, Herzig GP, et al. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA. 1988;85:4869-4873.
16. Gauwerky CE, Haluska FG, Tsujimoto Y, Nowell PC, Croce CM. Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene. Proc Natl Acad Sci U S A. 1988;85:8548-8552.
17. Lewis SM, Agard E, Suh S. Czyzyk L. Cryptic signals and the fidelity of V(D)J joining. Mol Cell Biol. 1997;17:3125-3136.
18. Corbett SJ, Tomlinson IM, Sonnhammer EL, Buck D, Winter G. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J Mol Biol. 1997; 270:587-597.
19. Yamada M, Wasserman R, Reichard BA, et al. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med. 1991;173:395-407.
20. Landau NR, Schatz DG, Rosa M, Baltimore D, Increased frequency of N-region insertion in a murine pre-B-cell line infected with a terminal deoxynucleotidyl transferase retroviral expression vector. Mol Cell Biol. 1987;7:3237-3243.
21. Kallenbach S, Doyen N, Fanton DA, Rougeon F. Three lymphoid-specific factors account for all junctional diversity characteristic of somatic assembly of T-cell receptor and immunoglobulin genes. Proc Natl Acad Sci USA. 1992;89:2799-2803.
22. Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D. Mice lacking TdT: mature animals with an immature lymphocyte repertoire. Science. 1993;261:1175-1178.
23. Komori T, Okada A, Stewart V, Alt FW. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 1993; 261:1171-1175.
24. Zhang Y, Cado D, Asarnow DM, et al. The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus. Immunity. 1995;3:439-447.
25. Ezekiel UR, Sun T, Bozek G, Storb U. The composition of coding joints formed in V(D)J recombination is strongly affected by the nucleotide sequence of the coding ends and their relationship to the recombination signal sequences. Mol Cell Biol. 1997;17:4191-4197.
26. Roth DB, Wilson JH. Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction. Mol Cell Biol. 1986;6:4295-4304.
27. Feeney AJ, Victor KD, Vu K, Nadel B, Chukwuocha RU. Influence of the V(D)J recombination mechanism on the formation of the primary T and B cell repertoires. Semin Immunol. 1994;6:155-163.
28. Milili M, Schiff C, Fougereau M, Tonnelle C. The VDJ repertoire expressed in human preB cells reflects the selection of bona fide heavy chains. Eur J Immunol. 1996;26:63-69.
29. Roes J, Huppi K, Rajewsky K, Sablitzky F. V gene rearrangement is required to fully activate the hypermutation mechanism in B cells. J Immunol. 1989;142:1022-1026.
30. Fukita Y, Jacobs H, Rajewsky K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity. 1998;9:105-114.
31. Roth DB, Porter TN, Wilson JH. Mechanisms of nonhomologous recombination in mammalian cells. Mol Cell Biol. 1985;5:2599-2607.
32. Wilson PC, de Bouteiller O, Liu YJ, et al. Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med. 1998;187:59-70.
33. Goossens T, Klein U, Kuppers R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci U S A. 1998;95:2463-2468.
34. Sale JE, Neuberger MS. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity. 1998;9:859-869.
35. Hiom K, Melek M, Gellert M. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell. 1998; 94:463-470.
36. Agrawal A, Eastman QM, Schatz DG. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature. 1998;394:744-751.
37. Roth DB, Chang XB, Wilson JH. Comparison of filler DNA at immune, nonimmune, and oncogenic rearrangements suggests multiple mechanisms of formation. Mol Cell Biol. 1989;9:3049-3057.
38. Reichel M, Gillert E, Nilson I, et al. Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation, Oncogene. 1998;17:3035-3044.
39. Gillert E, Leis T, Repp R. et al. A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells. Oncogens. 1999;16:4663-4671.
40. Storb U. Progress in understanding the mechanism and consequences of somatic hypermutation. Immunol Rev. 1998;162:5-11.
41. Bertocci B, Quint L. Delbos F, et al. Probing immunoglobulin gene hypermutation with microsatellites suggests a nonreplicative short patch DNA synthesis process. Immunity. 1998;9:257-265.
42. Klein U, Goossens T, Fischer M, et al. Somatic hypermutation in normal and transformed human B cells, Immunol Rev. 1998;162:261-280.
43. Papavasiliou F, Casellas R, Suh H, et al. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science. 1997;278: 298-301.
44. Han S. Dillon SR, Zheng B, et al. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science. 1997;278:301-305.
45. Hikida M, Mori M, Takai T, et al. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science. 1996;274:2092-2094.
46. Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science. 1996;274:2094-2097.
47. Meffre E, Papavasiliou F, Cohen P, et al. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells. J Exp Med. 1998;188:765-772.
48. Yu W, Nagaoka H, Jankovic M, et al. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization Nature. 1999;400:682-687